Gallery: US tech firms with the biggest returns since IPO

Enormous gains since listing

Laura Dew
clock • 1 min read

Investment Week takes a look at the best returns from US tech companies from a $1,000 investment at IPO.

Investment Week takes a look at the best returns from US tech companies from a $1,000 investment at IPO. Using data from Waterstones Management Group, we look at the ten companies which have given investors the biggest returns from a $1,000 investment.  Focusing on technology companies, the list covers major players including Amazon, Apple and Cisco Systems.  With some companies floating for as little as $7 per share, it shows there are significant gains to be made from backing companies early on.  For full data click here. Data as at 15 February. Source: Waterstones Manageme...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

While thematic funds offer diversification and a specialist knowledge base, investors must also consider the sensitivity to real bond yields inherent in these funds.

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
Deal volumes fell last year as rising interest rates brought the end of cheap money

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Ali H. Munawar, CEO of Pledge Therapeutics

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot